期刊
JOURNAL OF DIABETES AND ITS COMPLICATIONS
卷 26, 期 4, 页码 259-265出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jdiacomp.2012.04.007
关键词
Cardiomyopathy; Oxidative stress; Type I diabetes mellitus; Luteolin
资金
- Wannan Medical College
Objective: The study aimed to determine whether luteolin can confer cardioprotective effects against diabetic cardiomyopathy in relation to specific and quantitative markers of oxidative stress. Methods: We examined diabetic cardiomyopathy by left ventricular hemodynamic analysis. Myocardial oxidative stress was assessed by measuring the activity of superoxide dismutase (SOD) as well as the level of malondialdehyde (MDA). Hypolipidaemic effects of luteolin were also investigated in STZ-induced diabetic rats. Myocardial Akt/PKB phosphorylation, heme oxygenase-1 (HO-1) and connective tissue growth factor (CTGF) protein levels were measured by Western blot in all rats at the end of the study. Results: This study showed a significant increase in serum triacylglycerol (TG), total cholesterol (TC), lower density lipoprotein (LDL), MDA content, creatine kinase (CK), lactate dehydrogenase (LDH), and myocardial CTGF and a significant decrease in high density lipoprotein (HDL), SOD and Akt phosphorylation level in the diabetic group compared to the control group. Luteolin treatment induced a significant decrease in serum TG, TC, LDL, MDA, CK, LDH, and myocardial CTGF and a significant increase in HDL, SOD and Akt phosphorylation levels in comparison with the diabetic group. Conclusion: These results show that luteolin protects against the progression of diabetes mellitus-induced cardiac dysfunction by attenuation of myocardial oxidative stress probably through its antioxidant properties. (C) 2012 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据